Vascular Anomalies: MEK Inhibitor Rx Often Affects Skin

by | Dec 30, 2025 | Health

Spread the love
Study shows treating vascular anomalies with mitogen‑activated protein kinase inhibitors results in high rates of cutaneous adverse events.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments